| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $258K | — | -95.6% |
| R&D Expense | $2.9M | — | -78.6% |
| SG&A Expense | $4.9M | — | -28.4% |
| Operating Income | -$7.5M | — | +48.8% |
| Net Income | -$7.2M | — | +48.1% |
| EPS (Basic) | -$0.13 | — | +48.0% |
| EPS (Diluted) | -$0.13 | — | +48.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $56.1M | +39.4% | +14.8% |
| Current Assets | $57.6M | -14.4% | -22.9% |
| Total Assets | $59.0M | -14.4% | -24.0% |
| Current Liabilities | $5.5M | -38.1% | -81.2% |
| Total Liabilities | $6.1M | -38.5% | -86.1% |
| Stockholders' Equity | $52.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $15.9M | — | +496.4% |
| +56.5% |